Rural Clinics Battle Mountain Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 825 N 2nd St, Battle Mountain, NV 89820 Phone: 775-635-5753 Fax: 775-635-8028 |
News Archive
The PATH Malaria Vaccine Initiative (MVI) announced today that it has entered into a collaboration with Dutch biopharmaceutical company Crucell N.V. and GlaxoSmithKline (GSK). This collaboration is aimed at developing a second-generation vaccine against malaria—a deadly disease that kills close to 800,000 people annually, most of them young children under age five in Africa. MVI drives the development of malaria vaccines by joining its scientific, managerial, and field expertise with companies, universities, and governments to test potential malaria vaccines and invest in those with the most promise.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
Errors in administration of medication are a serious problem in long-term residential care. New research completed by the University of Warwick and the University of the West of England, Bristol (UWE) shows how a new electronic medication management system developed in the UK specifically for use in residential and nursing homes, has been shown to significantly reduce drug administration errors.
I'm professor Dieter Trau, and we are at the Analytica at booth, at hall B2, booth 116. The company we are presenting here is TIP Biosystems Pte Ltd.
A condition that can progress to myeloma could be identified in patients by their unusually frequent hospital visits, according to research presented at the 2019 NCRI Cancer Conference.
› Verified 2 days ago